Logo image of PRCT

PROCEPT BIOROBOTICS CORP (PRCT) Stock Analyst Earnings Estimates

NASDAQ:PRCT - Nasdaq - US74276L1052 - Common Stock - Currency: USD

62.25  -3.14 (-4.8%)

After market: 66 +3.75 (+6.02%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PRCT revenue by date.PRCT revenue by date.
34.47M
346.50%
75.01M
117.61%
136.191M
81.56%
227.53M
67.07%
320M
40.64%
421.68M
31.78%
503.65M
19.44%
596.77M
18.49%
693.51M
16.21%
755.51M
8.94%
EBITDA
YoY % growth
PRCT ebitda by date.PRCT ebitda by date.
-50.84M
-13.13%
-77.88M
-53.19%
-105.363M
-35.29%
-60.438M
42.64%
-32.849M
45.65%
-2.671M
91.87%
N/AN/AN/AN/A
EBIT
YoY % growth
PRCT ebit by date.PRCT ebit by date.
-54.16M
-13.31%
-80.72M
-49.04%
-109.17M
-35.25%
-97.687M
10.52%
-78.428M
19.71%
-49.915M
36.36%
-5.119M
89.74%
27.574M
638.62%
32.361M
17.36%
N/A
Operating Margin
PRCT operating margin by date.PRCT operating margin by date.
-157.12%-107.61%-80.16%-42.93%-24.51%-11.84%-1.02%4.62%4.67%N/A
EPS
YoY % growth
PRCT eps by date.PRCT eps by date.
N/A-1.89
39.05%
-2.24
-18.52%
-1.77
21.09%
-1.35
23.54%
-0.79
41.47%
-0.15
81.30%
0.36
344.83%
0.58
60.56%
0.93
59.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.33
38.09%
-0.36
29.14%
-0.36
28.60%
-0.32
18.76%
-0.28
16.61%
-0.26
29.15%
-0.25
28.71%
-0.22
32.67%
-0.16
42.19%
Revenue
Q2Q % growth
68.115M
56.30%
67.507M
51.57%
76.835M
44.01%
82.024M
40.52%
92.319M
35.53%
96.074M
42.32%
106.15M
38.15%
113.19M
38.00%
123.08M
33.32%
EBITDA
Q2Q % growth
-8.906M
65.41%
-11.406M
56.90%
-9.402M
61.43%
-7.423M
60.19%
-6.801M
23.63%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-19.154M
35.20%
-20.993M
24.07%
-20.867M
22.22%
-19.717M
12.08%
-18.201M
4.97%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.40
21.57%
-0.500.1019.73%
Q2 2024
Q2Q % growth
-0.50
10.71%
-0.530.036.21%
Q1 2024
Q2Q % growth
-0.51
19.05%
-0.570.069.99%
Q4 2023
Q2Q % growth
-0.54
3.57%
-0.45-0.09-20.63%
Q3 2023
Q2Q % growth
-0.51 -0.520.012.81%
Q2 2023
Q2Q % growth
-0.56
-30.23%
-0.580.023.89%
Q1 2023
Q2Q % growth
-0.63
-61.54%
-0.59-0.04-6.23%
Q4 2022
Q2Q % growth
-0.56
-33.33%
-0.560.00-0.87%
Q3 2022
Q2Q % growth
-0.51
58.20%
-0.49-0.02-3.90%
Q2 2022
Q2Q % growth
-0.43 -0.490.0612.54%
Q1 2022
Q2Q % growth
-0.39 -0.480.0919.08%
Q4 2021
Q2Q % growth
-0.42 -0.40-0.02-5.58%
Q3 2021
Q2Q % growth
-1.22 -0.43-0.79-186.49%
PRCT Yearly EPS VS EstimatesPRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
58.37M
66.29%
54.247M4.123M7.60%
Q2 2024
Q2Q % growth
53.353M
61.17%
51.167M2.186M4.27%
Q1 2024
Q2Q % growth
44.539M
82.51%
42.409M2.13M5.02%
Q4 2023
Q2Q % growth
43.581M
83.27%
42.903M678K1.58%
Q3 2023
Q2Q % growth
35.102M
72.49%
35.099M3K0.01%
Q2 2023
Q2Q % growth
33.104M
98.35%
31.065M2.039M6.56%
Q1 2023
Q2Q % growth
24.404M
71.86%
24.841M-437K-1.76%
Q4 2022
Q2Q % growth
23.78M
134.52%
23.562M218K0.93%
Q3 2022
Q2Q % growth
20.35M
134.72%
17.552M2.798M15.94%
Q2 2022
Q2Q % growth
16.69M
6.52%
14.694M1.996M13.58%
Q1 2022
Q2Q % growth
14.2M 12.351M1.849M14.97%
Q4 2021
Q2Q % growth
10.14M
214.91%
9.133M1.007M11.03%
Q3 2021
Q2Q % growth
8.67M
310.90%
7.232M1.438M19.88%
Q2 2021
Q2Q % growth
15.668M
555.84%
%
PRCT Yearly Revenue VS EstimatesPRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.05% 2.78% 0.06% 0.4%
Revenue0.02% 0.01% 0% 0%